Jeffrey Paley, Director at Travere Therapeutics, holds 79.66K shares in Avenue Therapeutics (Ticker: ATXI), holds ― shares in Immune Pharmaceuticals (Ticker: IMNPQ), holds 51.66K shares in Travere Therapeutics (Ticker: TVTX). Most recently, Jeffrey Paley Bought ― shares of Avenue Therapeutics on Dec 12, 2018 for an estimated value of 78.50K.
What is the percentage of profitable transactions made by Jeffrey Paley?
The percentage of profitable transactions made by Jeffrey Paley is 50%.
What is the average return per transaction made by Jeffrey Paley?
The average return per transaction made by Jeffrey Paley is -49.10%.
What stocks does Jeffrey Paley hold?
Jeffrey Paley holds: TVTX, IMNPQ, ATXI stocks.
What was Jeffrey Paley’s latest transaction?
Jeffrey Paley latest transaction was an Informative Buy of $78.50K.
What was Jeffrey Paley's most profitable transaction?
Jeffrey Paley’s most profitable transaction was an Informative Buy of ATXI stock on December 12, 2018. The return on the trade was 43.20%.
What is Jeffrey Paley's role in Travere Therapeutics?
Jeffrey Paley's role in Travere Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.